Pharmacy
Researchers found nearly a third of approvals from 2001 through 2010 had major safety issues years after they were widely available to patients.|
Health plans need stability, the former CMS leader says, to be able to offer high-quality and affordable coverage.
As analytics programs look for population data, some contracts are shifting accountability to drugmakers.
Covering treatment for the 35,000 of Louisiana's uninsured and Medicaid-dependent residents with hepatitis C would cost the state $764 million.
Leapfrog Group says 30 percent of hospitals fully meet the four criteria for bar code medication administration, though 74 percent meet the group's two CPOE criteria.
Assemblymember David Chiu (D-San Francisco) has introduced a bill that would strengthen intra-agency collaboration on drug cost-saving strategies.
Insurer is engaging in a request for proposals for a new pharmacy benefit manager following the end of its contract.
Leaders consistently included shortages and drug pricing among their top concerns in the survey over the last two years.
Patent laws, government incentives, meant to encourage development of less-profitable drugs, enable some companies to get a leg up, set high prices.
Congressional records show those eight, including Celgene and Mylan, kicked in an extra $4.42 million versus that quarter last year.